Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Microbiome Partnering Terms and Agreements 2010 to 2023

      Research and Markets Logo

      News provided by

      Research and Markets

      Jun 02, 2023, 18:45 ET

      Share this article

      Share this article


      DUBLIN, June 2, 2023 /PRNewswire/ -- The "Global Microbiome Partnering Terms and Agreements 2010 to 2023" report has been added to  ResearchAndMarkets.com's offering.


      This report provides an understanding and access to the microbiome partnering deals and agreements entered into by the world's leading healthcare companies.

      • Trends in microbiome partnering deals
      • Disclosed headlines, upfronts, milestones and royalties by stage of development
      • Microbiome partnering contract documents
      • Top microbiome deals by value

      The Global Microbiome Partnering Terms and Agreements report provides an understanding and access to the microbiome partnering deals and agreements entered into by the world's leading healthcare companies.

      The report provides a detailed understanding and analysis of how and why companies enter microbiome partnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors microbiome technology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

      Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

      This report contains links to online copies of actual microbiome deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

      Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

      For example, analyzing actual company deals and agreements allows assessment of the following:

      • What is actually granted by the agreement to the partner company?
      • What exclusivity is granted?
      • What are the precise rights granted or optioned?
      • What is the payment structure for the deal?
      • How are sales and payments audited?
      • What is the deal term?
      • How are the key terms of the agreement defined?
      • How are IPRs handled and owned?
      • Who is responsible for commercialization?
      • Who is responsible for development, supply, and manufacture?
      • How is confidentiality and publication managed?
      • How are disputes to be resolved?
      • Under what conditions can the deal be terminated?
      • What happens when there is a change of ownership?
      • What sublicensing and subcontracting provisions have been agreed?
      • Which boilerplate clauses does the company insist upon?
      • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
      • Which jurisdiction does the company insist upon for agreement law?

      Report scope

      The report is intended to provide the reader with an in-depth understanding and access to microbiome trends and structure of deals entered into by leading companies worldwide.

      Global Microbiome Partnering Terms and Agreements 2010 to 2023 includes:

      • Trends in microbiome dealmaking in the biopharma industry since 2010
      • Access to headline, upfront, milestone and royalty data
      • Access to over 250 microbiome deal records and contract documents where available
      • The leading microbiome deals by value since 2010
      • Most active microbiome dealmakers since 2010
      • The leading microbiome partnering resources

      In Global Microbiome Partnering Terms and Agreements 2010 to 2023, the available contracts are listed by:

      • Company A-Z
      • Headline value
      • Stage of development at signing
      • Deal component type
      • Specific therapy and technology target

      Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

      Key Topics Covered:

      Chapter 1 - Introduction

      Chapter 2 - Trends in microbiome dealmaking
      2.1. Introduction
      2.2. Microbiome partnering over the years
      2.3. Most active microbiome dealmakers
      2.4. Microbiome partnering by deal type
      2.5. Microbiome partnering by therapy area
      2.6. Deal terms for microbiome partnering
      2.6.1 Microbiome partnering headline values
      2.6.2 Microbiome deal upfront payments
      2.6.3 Microbiome deal milestone payments
      2.6.4 Microbiome royalty rates

      Chapter 3 - Leading microbiome deals
      3.1. Introduction
      3.2. Top microbiome deals by value

      Chapter 4 - Most active microbiome dealmakers
      4.1. Introduction
      4.2. Most active microbiome dealmakers
      4.3. Most active microbiome partnering company profiles

      Chapter 5 - Microbiome contracts dealmaking directory
      5.1. Introduction
      5.2. Microbiome contracts dealmaking directory

      Chapter 6 - Microbiome dealmaking by technology type

      Companies Mentioned

      • 4D Pharma
      • 9 Meters Biopharma
      • Aarhus University
      • Abbott Laboratories
      • Abbvie
      • ADL Bionatur Solutions
      • ADM
      • AIDS Clinical Trials Group
      • Alimentary Health
      • Allergan
      • ALS Association
      • Amag Pharmaceuticals
      • American Type Culture Collection (ATCC)
      • Ancilia Biosciences
      • AnimalBiome
      • AntibioTx
      • Arc Bio
      • Archer Daniels Midland Company
      • Arena Pharmaceuticals
      • Argonne National Laboratory
      • Ariana Pharma
      • Arranta Bio
      • Artizan Biosciences
      • Assembly Biosciences
      • AstraZeneca
      • Aurealis Therapeutics
      • Azitra
      • BASF
      • Bayer
      • Bayer CropScience
      • Bayer Healthcare
      • Baylor College of Medicine
      • Baylor Miraca Genetics Laboratories
      • Beam Therapeutics
      • Bertin Pharma
      • Bill and Melinda Gates Foundation
      • Bio-Me
      • Bio-Rad Laboratories
      • BIOASTER
      • Biocodex Microbiota Foundation
      • Biocogent
      • Biocore
      • Biofortis
      • Biohaven Pharmaceuticals
      • BiomeBank
      • Biomecite Diagnostics
      • Biomedical Advanced Research and Development Authority
      • Biomica
      • Biomillenia
      • Biomodels
      • BiomX
      • BionX Medical Technologies
      • Bio Palette
      • Biosortia Pharmaceuticals
      • Bloom Science
      • Boehringer Ingelheim
      • Boston University School of Medicine
      • Brigham and Women's Hospital
      • Bristol-Myers Squibb
      • Brown University
      • Cancer Research UK
      • CARB-X
      • Carbiotix
      • Cargill
      • Cedars-Sinai Medical Center
      • Centers for Disease Control and Prevention
      • Centre Leon Berard
      • Centre National de la Recherche Scientifique
      • Centro Sperimentale del Latte
      • Children's Hospital Boston
      • Circuit Clinical
      • Clalit Health Services
      • CN Bio
      • Commense
      • Companion PBx
      • Compass Minerals Plant Nutrition
      • ConsortiaTX
      • COPD Foundation
      • CoreBiome
      • Cornell University
      • CosmosID
      • Crohn's and Colitis Foundation of America
      • CryoXtract
      • Dana-Farber Cancer Institute
      • DayTwo
      • DDL Diagnostic Laboratory
      • Debiopharm
      • Defense Advanced Research Projects Agency
      • Department of Health and Human Services
      • Dermala
      • Diversigen
      • DuPont
      • DuPont Pharmaceuticals
      • DuPont Pioneer
      • Eagle Genomics
      • EcoMetrix
      • Elanco
      • Eligo Bioscience
      • Emulate
      • EnBiotix
      • Enterome Bioscience
      • EpiBiome
      • European Commission
      • Evah
      • Evelo Biosciences
      • Evogene
      • Evolve BioSystems
      • Evotec
      • ExeGi Pharma
      • Felix Biotechnology
      • Ferring Pharmaceuticals
      • Finch Therapeutics
      • Florida International University
      • Food Marble Digestive Health
      • Forsyth Institute
      • French National Institute for Agricultural Research
      • Fundacion Progreso y Salud
      • Galmed Pharmaceuticals
      • Genentech
      • General Automation Lab Technologies
      • Genetic Analysis
      • Genewiz
      • Genome and Company
      • GenomeQuest
      • Georges Francois Leclerc Center
      • German Cryo
      • Gilead Sciences
      • Ginkgo BioWorks
      • GlaxoSmithKline
      • Glycosyn
      • Gnubiotics Sciences
      • Greenteaspoon
      • Hackensack Meridian Health
      • Hadassah Medical Center
      • Hamilton Company
      • Harvard School of Public Health
      • Harvard T.H. Chan School of Public Health
      • Harvard University
      • Helomics
      • HLH BioPharma Vertriebs
      • Holobiome
      • Horizon 2020
      • Hospital of University of Strasbourg
      • Hudson Institute of Medical Research
      • Human Longevity

      For more information about this report visit https://www.researchandmarkets.com/r/xqlv7o

      About ResearchAndMarkets.com
      ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]
       
      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900
       
      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.